These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 30597344)

  • 1. Natural history and clinical outcomes in patients with portal vein thrombosis by etiology: A retrospective cohort study.
    Acuna-Villaorduna A; Tran V; Gonzalez-Lugo JD; Azimi-Nekoo E; Billett HH
    Thromb Res; 2019 Feb; 174():137-140. PubMed ID: 30597344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of factors related to recanalization of portal vein thrombosis in liver cirrhosis: a retrospective cohort study.
    Shi Y; Feng W; Cai J; Wang Z; Pu Y; Mao W; Zhan K; Chen D
    BMC Gastroenterol; 2024 Jul; 24(1):224. PubMed ID: 39003447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Harmful and Beneficial Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis.
    La Mura V; Braham S; Tosetti G; Branchi F; Bitto N; Moia M; Fracanzani AL; Colombo M; Tripodi A; Primignani M
    Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1146-1152.e4. PubMed ID: 29066371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulation in Cirrhosis and Portal Vein Thrombosis Is Safe and Improves Prognosis in Advanced Cirrhosis.
    Noronha Ferreira C; Reis D; Cortez-Pinto H; Tato Marinho R; Gonçalves A; Palma S; Leite I; Rodrigues T; Pedro AJ; Alexandrino P; Serejo F; Sobral Dias M; Ferreira P; Vasconcelos M; Damião F; Xavier Brito L; Baldaia C; Fatela N; Ramalho F; Velosa J
    Dig Dis Sci; 2019 Sep; 64(9):2671-2683. PubMed ID: 30852769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of anticoagulation in more advanced portal vein thrombosis in patients with liver cirrhosis.
    Chen H; Liu L; Qi X; He C; Wu F; Fan D; Han G
    Eur J Gastroenterol Hepatol; 2016 Jan; 28(1):82-9. PubMed ID: 26513611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Portal vein thrombosis and liver cirrhosis: Long-term anticoagulation is effective and safe.
    Bergère M; Erard-Poinsot D; Boillot O; Valette PJ; Guillaud O; Chambon-Augoyard C; Dumortier J
    Clin Res Hepatol Gastroenterol; 2019 Aug; 43(4):395-402. PubMed ID: 30578107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Portal vein thrombosis after partial splenic embolization in liver cirrhosis: efficacy of anticoagulation and long-term follow-up.
    Cai M; Zhu K; Huang W; Meng X; He K; Zhou B; Guo Y; Chen J; Shan H
    J Vasc Interv Radiol; 2013 Dec; 24(12):1808-16. PubMed ID: 24099787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Portal vein thrombosis after laparoscopic sleeve gastrectomy: presentation and management.
    Belnap L; Rodgers GM; Cottam D; Zaveri H; Drury C; Surve A
    Surg Obes Relat Dis; 2016 Dec; 12(10):1787-1794. PubMed ID: 27178606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient portal vein thrombosis in liver cirrhosis.
    Qi X; Guo X; Yoshida EM; Méndez-Sánchez N; De Stefano V; Tacke F; Mancuso A; Sugawara Y; Yang SS; Teschke R; Arora A; Valla DC
    BMC Med; 2018 Jun; 16(1):83. PubMed ID: 29871683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis.
    Senzolo M; M Sartori T; Rossetto V; Burra P; Cillo U; Boccagni P; Gasparini D; Miotto D; Simioni P; Tsochatzis E; A Burroughs K
    Liver Int; 2012 Jul; 32(6):919-27. PubMed ID: 22435854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulation in non-malignant portal vein thrombosis is safe and improves hepatic function.
    Scheiner B; Stammet PR; Pokorny S; Bucsics T; Schwabl P; Brichta A; Thaler J; Lampichler K; Ba-Ssalamah A; Ay C; Ferlitsch A; Trauner M; Mandorfer M; Reiberger T
    Wien Klin Wochenschr; 2018 Jul; 130(13-14):446-455. PubMed ID: 29916054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis.
    Delgado MG; Seijo S; Yepes I; Achécar L; Catalina MV; García-Criado A; Abraldes JG; de la Peña J; Bañares R; Albillos A; Bosch J; García-Pagán JC
    Clin Gastroenterol Hepatol; 2012 Jul; 10(7):776-83. PubMed ID: 22289875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Portal vein thrombosis patients harboring JAK2V617F have poor long-term outcomes despite anticoagulation.
    Naymagon L; Tremblay D; Zubizarreta N; Moshier E; Schiano T; Mascarenhas J
    J Thromb Thrombolysis; 2020 Oct; 50(3):652-660. PubMed ID: 32034618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of anticoagulation in non-malignant portal vein thrombosis in patients with liver cirrhosis.
    Artaza T; Lopes M; Romero M; Gómez AZ; de la Cruz G; Sánchez JJ; González C; Gómez R
    Gastroenterol Hepatol; 2018 Dec; 41(10):611-617. PubMed ID: 30049580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis: A Systematic Review and Meta-analysis.
    Loffredo L; Pastori D; Farcomeni A; Violi F
    Gastroenterology; 2017 Aug; 153(2):480-487.e1. PubMed ID: 28479379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticoagulation Favors Thrombus Recanalization and Survival in Patients With Liver Cirrhosis and Portal Vein Thrombosis: Results of a Meta-Analysis.
    Wang L; Guo X; Xu X; De Stefano V; Plessier A; Noronha Ferreira C; Qi X
    Adv Ther; 2021 Jan; 38(1):495-520. PubMed ID: 33155180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence of Hepatocellular Carcinoma Does Not Affect Course and Response to Anticoagulation of Bland Portal Vein Thrombosis in Cirrhotic Patients.
    Benevento F; Pecorelli A; Stefanescu H; Sparchez Z; Vukotic R; Pettinari I; Grigoras CA; Tovoli F; Ravaioli F; Stefanini B; Andreone P; Piscaglia F
    J Hepatocell Carcinoma; 2023; 10():473-482. PubMed ID: 37007210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of anticoagulation on outcomes in acute non-cirrhotic and non- malignant portal vein thrombosis: a retrospective observational study.
    Hall TC; Garcea G; Metcalfe M; Bilk D; Rajesh A; Dennison A
    Hepatogastroenterology; 2013; 60(122):311-7. PubMed ID: 23858545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Portal vein thrombosis in liver cirrhosis: incidence, management, and outcome.
    Fujiyama S; Saitoh S; Kawamura Y; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Suzuki Y; Suzuki F; Arase Y; Ikeda K; Kumada H
    BMC Gastroenterol; 2017 Oct; 17(1):112. PubMed ID: 29070023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulation in Cirrhosis: Evidence for the Treatment of Portal Vein Thrombosis and Applications for Prophylactic Therapy.
    Martens K; McMurry HS; Koprowski S; Hum J; Haraga J; Jou JH; Shatzel JJ
    J Clin Gastroenterol; 2022 Jul; 56(6):536-545. PubMed ID: 35537133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.